Drug Profile
Research programme: muscarinic acetylcholine M4 receptor allosteric modulators - Eli Lilly and Company
Alternative Names: LY-2033298Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Eli Lilly and Company
- Class 2 ring heterocyclic compounds; Amides; Small molecules
- Mechanism of Action Muscarinic M4 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Schizophrenia
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Schizophrenia in United Kingdom
- 23 Jan 2008 Preclinical trials in Schizophrenia in United Kingdom (unspecified route)